http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI1006602-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_021d58e90a2685d49f7962a205920a51
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42
filingDate 2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea1e0774ba3f890eb11763616d76e86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886d0ab3f903d4530d692e7d2efbe70b
publicationDate 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI1006602-A2
titleOfInvention compound, method for modulating a histamine receptor in an individual, pharmaceutical composition, kit and method for treating a cognitive disorder or a disorder induced by at least one symptom associated with cognitive impairment
abstract compound, use of a compound, pharmaceutical composition and kit are described new novel heterocyclic compounds that can be used to modulate a histamine receptor in an individual. pyrido [4,3-b] indoles are described as pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter mediated disorder and / or a neuronal disorder.
priorityDate 2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412844144

Total number of triples: 18.